Literature DB >> 27716934

Patching it together: epicutaneous vaccination with heat-labile Escherichia coli toxin against birch pollen allergy.

S S Killingbeck1, M Q Ge1, A Haczku1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 27716934      PMCID： PMC6279960          DOI： 10.1111/all.13064

Source DB:  PubMed          Journal:  Allergy        ISSN： 0105-4538            Impact factor:   13.146


× No keyword cloud information.
  26 in total

1.  Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange.

Authors:  Marijn van der Neut Kolfschoten; Janine Schuurman; Mario Losen; Wim K Bleeker; Pilar Martínez-Martínez; Ellen Vermeulen; Tamara H den Bleker; Luus Wiegman; Tom Vink; Lucien A Aarden; Marc H De Baets; Jan G J van de Winkel; Rob C Aalberse; Paul W H I Parren
Journal:  Science       Date:  2007-09-14       Impact factor: 47.728

Review 2.  Eosinophilic gastrointestinal disorders.

Authors:  Amal Assa'ad
Journal:  Allergy Asthma Proc       Date:  2009 Jan-Feb       Impact factor: 2.587

Review 3.  Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report.

Authors:  M A Calderón; T Casale; L Cox; C A Akdis; A W Burks; H S Nelson; M Jutel; P Demoly
Journal:  Allergy       Date:  2013-07       Impact factor: 13.146

Review 4.  Allergen immunotherapy now and in the future.

Authors:  Harold S Nelson
Journal:  Allergy Asthma Proc       Date:  2016-07       Impact factor: 2.587

5.  Immune regulation by intralymphatic immunotherapy with modular allergen translocation MAT vaccine.

Authors:  A Zaleska; T Eiwegger; O Soyer; W van de Veen; C Rhyner; M B Soyka; C Bekpen; D Demiröz; A Treis; S Söllner; O Palomares; W W Kwok; H Rose; G Senti; T M Kündig; N Ozoren; M Jutel; C A Akdis; R Crameri; M Akdis
Journal:  Allergy       Date:  2014-07-12       Impact factor: 13.146

Review 6.  Role of regulatory B cells in immune tolerance to allergens and beyond.

Authors:  Willem van de Veen; Barbara Stanic; Oliver F Wirz; Kirstin Jansen; Anna Globinska; Mübeccel Akdis
Journal:  J Allergy Clin Immunol       Date:  2016-09       Impact factor: 10.793

Review 7.  Allergen-specific immunotherapy: is it vaccination against toxins after all?

Authors:  M F Bachmann; T M Kündig
Journal:  Allergy       Date:  2016-09-28       Impact factor: 13.146

Review 8.  Specific allergen immunotherapy for the treatment of atopic eczema: a Cochrane systematic review.

Authors:  H H Tam; M A Calderon; L Manikam; H Nankervis; I G Núñez; H C Williams; S R Durham; R J Boyle
Journal:  Allergy       Date:  2016-06-22       Impact factor: 13.146

Review 9.  Designing vaccines based on biology of human dendritic cell subsets.

Authors:  Karolina Palucka; Jacques Banchereau; Ira Mellman
Journal:  Immunity       Date:  2010-10-29       Impact factor: 31.745

10.  Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala.

Authors:  Ronald H Behrens; Jakob P Cramer; Tomas Jelinek; Hilary Shaw; Frank von Sonnenburg; Darren Wilbraham; Thomas Weinke; David J Bell; Edwin Asturias; Hermann L Enkerlin Pauwells; Roberto Maxwell; Mercedes Paredes-Paredes; Gregory M Glenn; Shailesh Dewasthaly; Donald M Stablein; Zhi-Dong Jiang; Herbert L DuPont
Journal:  Lancet Infect Dis       Date:  2013-11-29       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.